What is Epic Sciences?
Founded in 2008 and headquartered in San Diego, Epic Sciences Inc. is at the forefront of liquid biopsy technology. The company's proprietary platform enables the molecular characterization of circulating tumor cells (CTCs) directly from a patient's blood sample. This innovative approach provides critical insights into tumor heterogeneity and evolution, aiding oncologists in making more informed treatment decisions. Epic Sciences' technology is designed to support personalized medicine by offering a non-invasive method to monitor disease progression and treatment response, thereby enhancing patient care pathways in oncology.
How much funding has Epic Sciences raised?
Epic Sciences has raised a total of $220.5M across 9 funding rounds:
Series C
$30M
Debt
$15M
Series D
$40M
Other Financing Round
$52M
Debt
$1M
Series F
$43M
Series G
$24M
Series C (2014): $30M supported by Roche, Arcus Ventures, Domain Associates, and Pfizer Venture Investments
Debt (2015): $15M featuring Silicon Valley Bank
Series D (2017): $40M backed by Domain Associates, Hermed Capital, Altos Capital Partners, and Genomic Health
Other Financing Round (2018): $52M with participation from Blue Ox Healthcare Partners
Debt (2020): $1M led by PPP
Series F (2022): $43M supported by Arsenal Capital Partners and Blue Ox Healthcare Partners
Series G (2023): $24M featuring Deerfield, HC Domain Ventures, Arsenal Capital Partners, Labcorp, and Blue Ox Healthcare Partners
Key Investors in Epic Sciences
Deerfield
Deerfield Management is an investment firm focused on advancing healthcare through investment, intelligence, and philanthropy. The firm supports companies across the healthcare ecosystem with flexible funding models and drives innovation using AI, data, and market research.
Arsenal Capital Partners
Arsenal Capital Partners is a leading private equity firm specialized in investments in middle-market industrial growth and healthcare companies. Since its inception in 2000, the firm has distinguished itself through a "build-for-tomorrow" philosophy, focusing on high-growth, technology-, and innovation-rich businesses that are strategically important to their respective markets.
Blue Ox Healthcare Partners
Blue Ox Healthcare Partners is a commercial-stage growth investor focused on precision health and individualized medicine. The company seeks to invest in growth-stage healthcare companies that offer technology-enabled innovations aimed at improving healthcare delivery, affordability, and precision health.
What's next for Epic Sciences?
With its substantial enterprise-level funding and a recent strategic investment, Epic Sciences is well-positioned for accelerated growth and market expansion. The company's focus on advancing CTC analysis technology suggests a strategic direction towards further refining its diagnostic capabilities and potentially broadening its application across various cancer types. Future developments are likely to involve enhancing the sensitivity and specificity of its tests, expanding its commercial reach, and forging new partnerships within the healthcare ecosystem to integrate its diagnostic solutions into standard clinical practice. This sustained financial backing indicates strong investor confidence in Epic Sciences' mission to revolutionize cancer diagnostics and improve patient outcomes through precision medicine.
See full Epic Sciences company page
